Figure 5From: Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial Median differences in nerve conduction parameters between treatment groups: pregabalin 600 mg/d vs. placebo. Back to article page